China’s pharma stocks gain favours amid ‘greater’ progress of innovative drugs
Chinese pharmaceutical companies are ramping up global expansion and the sector, set to sustain rapid growth with the upcoming third-quarter earnings releases, could see a further lift in market sentiment, analysts said.
In the first three quarters, domestic innovative drugs accounted for 80 per cent of all innovative medicines approved in China, according to the Ministry of Industry and Information Technology.
“Research progress has been made across multiple therapeutic areas including...
此摘要由5News从媒体的公开信息源汇聚而成。 包含完整背景的全文在www.scmp.com — 内容归South China Morning Post - Business所有。
